Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   THE JOURNAL OF NEPHRO-UROLOGY MONTHLY   NOVAMBER 2016 , Volume 8 , Number 6; Page(s) 0 To 0.
 
Paper: 

EVALUATION OF ANTI-TOXOPLASMA GONDII ANTIBODIES IN HEMODIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE IN SARI, IRAN

 
 
Author(s):  SEYYEDPOUR SEYYED HOSEIN, AFSHAR PARVANEH*, BARZEGARNEJAD AYOUB, KALHORI SHAMSI, AGAH REZA
 
* REFERRAL LABORATORY, MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, SARI, IR IRAN
 
Abstract: 

Background: Toxoplasma gondii has worldwide distribution and is one of the most prevalent infectious agents in humans.
Objectives: The aim of this study was to determine the prevalence of anti- Toxoplasma gondii antibodies in hemodialysis patients with chronic kidney disease (CKD) in the hemodialysis unit of Fatemeh Zahra hospital at the Mazandaran University of Medical Sciences in Sari, Iran.
Methods: Seventy-three patients with CKD and 145 healthy volunteers were assessed for anti- Toxoplasma gondii (IgG, IgM, and IgA) antibodies using a conventional ELISA technique.
Results: The anti- Toxoplasma gondii IgG antibody was detected in 80.8% of the cases in the patient group, while 31.5% of the cases in the CKD patient group and 31.8% in the control group were found to be positive for the anti-Toxoplasma gondii IgA antibody. All the patients in the CKD group were negative for the anti-Toxoplasma gondii IgM antibody, although 2.76% of the healthy volunteers were found to be positive. The present study suggests that there was no significant difference between the hemodialysis patient group and the healthy volunteers.
Conclusions: The epidemiological data collected in this study could serve as a reference for future studies and may be useful in developing preventive and educational strategies, and consequently reducing healthcare expenditure.

 
Keyword(s): TOXOPLASMOSIS, HEMODIALYSIS, ELISA, IGM, IGG, IGA
 
 
References: 
  • ندارد
  •  
 
Click to Cite.
APA: Copy

SEYYEDPOUR, S., & Afshar, P., & BARZEGARNEJAD, A., & Kalhori, S., & Agah, R. (2016). EVALUATION OF ANTI-TOXOPLASMA GONDII ANTIBODIES IN HEMODIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE IN SARI, IRAN. THE JOURNAL OF NEPHRO-UROLOGY MONTHLY, 8(6), 0-0. https://www.sid.ir/en/journal/ViewPaper.aspx?id=570630



Vancouver: Copy

SEYYEDPOUR SEYYED HOSEIN, Afshar Parvaneh, BARZEGARNEJAD AYOUB, Kalhori Shamsi, Agah Reza. EVALUATION OF ANTI-TOXOPLASMA GONDII ANTIBODIES IN HEMODIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE IN SARI, IRAN. THE JOURNAL OF NEPHRO-UROLOGY MONTHLY. 2016 [cited 2021May12];8(6):0-0. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=570630



IEEE: Copy

SEYYEDPOUR, S., Afshar, P., BARZEGARNEJAD, A., Kalhori, S., Agah, R., 2016. EVALUATION OF ANTI-TOXOPLASMA GONDII ANTIBODIES IN HEMODIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE IN SARI, IRAN. THE JOURNAL OF NEPHRO-UROLOGY MONTHLY, [online] 8(6), pp.0-0. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=570630.



 
  pdf-File
Yearly Visit 26
 
Latest on Blog
Enter SID Blog